InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,900.00
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.36
(
0.00%
)
Bitcoin
60,884.49
(
0.35%
)
Post# of 252782
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pharmaclown35

Send PM Follow Ignore
Followers 1
Posts 202
Boards Moderated 0
Alias Born 01/23/2008

pharmaclown35

Re: amylinterry post# 72485

Saturday, 01/31/2009 7:05:55 PM

Saturday, January 31, 2009 7:05:55 PM

Post# of 252782
i am not so sure. the pancreatitis issue is still unresolved. didn't the FDA ask for additional data back in December?

the obesity space is probably under heightened scrutiny following the failure of the entire CB-1 class of drugs.

Also, Vivus reported disappointing results as well. Orexigen's results were also mediocre.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up